Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126346401 | 12634640 | 1 | I | 20160621 | 20160729 | 20160808 | 20160808 | EXP | GB-MHRA-MIDB-8F262AB7-7348-48B6-9982-BD12C81FE9A8 | GB-TAKEDA-2016TJP016576 | TAKEDA | 79.00 | YR | M | Y | 0.00000 | 20160808 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126346401 | 12634640 | 1 | PS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | 15 MG, QD | Y | 20406 | 15 | MG | QD | ||||||
| 126346401 | 12634640 | 2 | C | ADCAL D3 | CALCIUM CARBONATECHOLECALCIFEROL | 1 | UNK UNK, BID | U | 0 | BID | |||||||||
| 126346401 | 12634640 | 3 | C | ALENDRONIC ACID | ALENDRONIC ACID | 1 | 70 MG, 1/WEEK | U | 0 | 70 | MG | /wk | |||||||
| 126346401 | 12634640 | 4 | C | ASPIRIN (E.C.) | ASPIRIN | 1 | 75 MG, QD | U | 0 | 75 | MG | QD | |||||||
| 126346401 | 12634640 | 5 | C | ATORVASTATIN | ATORVASTATIN | 1 | 20 MG, QD (AT NIGHT) | U | 0 | 20 | MG | QD | |||||||
| 126346401 | 12634640 | 6 | C | CARBOCISTEINE | CARBOCYSTEINE | 1 | 750 MG, TID | U | 0 | 750 | MG | TID | |||||||
| 126346401 | 12634640 | 7 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | 50 ?G, UNK | U | 0 | 50 | UG | ||||||||
| 126346401 | 12634640 | 8 | C | FLUCLOXACILLIN | FLUCLOXACILLIN | 1 | 500 MG, QID | 24000 | MG | U | 0 | 500 | MG | QID | |||||
| 126346401 | 12634640 | 9 | C | FOLIC ACID. | FOLIC ACID | 1 | 5 MG, QD | U | 0 | 5 | MG | QD | |||||||
| 126346401 | 12634640 | 10 | C | RAMIPRIL. | RAMIPRIL | 1 | 2.5 MG, QD (AT NIGHT) | 32.5 | MG | U | 0 | 2.5 | MG | QD | |||||
| 126346401 | 12634640 | 11 | C | RANITIDINE. | RANITIDINE | 1 | 150 MG, QD (IN THE MORNING) | 300 | MG | U | 0 | 150 | MG | QD | |||||
| 126346401 | 12634640 | 12 | C | SALAMOL /00139501/ | 2 | Respiratory (inhalation) | 100 ?G, QID | U | 0 | 100 | UG | QID | |||||||
| 126346401 | 12634640 | 13 | C | SALBUTAMOL | ALBUTEROL | 1 | 2.5MG/2.5ML NEBULISER LIQUID UNIT DOSE VIALS | U | 0 | ||||||||||
| 126346401 | 12634640 | 14 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | (400/12), BID | U | 0 | BID | |||||||||
| 126346401 | 12634640 | 15 | C | TIOTROPIUM BROMIDE | TIOTROPIUM BROMIDE | 1 | Respiratory (inhalation) | 180 ?G, QD (IN THE MORNING) | U | 0 | 180 | UG | QD | ||||||
| 126346401 | 12634640 | 16 | C | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | 120 MG, QD | 1560 | MG | U | 0 | 120 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126346401 | 12634640 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126346401 | 12634640 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126346401 | 12634640 | Dyspnoea | |
| 126346401 | 12634640 | Hyponatraemia | |
| 126346401 | 12634640 | Infective exacerbation of chronic obstructive airways disease | |
| 126346401 | 12634640 | Productive cough |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126346401 | 12634640 | 1 | 20160622 | 0 | ||
| 126346401 | 12634640 | 8 | 20160609 | 20160713 | 0 | |
| 126346401 | 12634640 | 10 | 20160608 | 0 | ||
| 126346401 | 12634640 | 11 | 20160623 | 0 | ||
| 126346401 | 12634640 | 16 | 20160608 | 0 |